Estados financieros detallados de Monopar Therapeutics Inc. (MNPR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $101.45, MNPR presenta beneficios negativos (P/E no significativo) y un ROE del -13.08%. La capitalización bursátil es de $680M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $280355 | $935319 | $1.8M | $2.0M | $4.1M | $6.5M | $7.6M | $5.6M | $13.0M | $9.90B |
| Generales y Administrativos | $912474 | $1.2M | $1.6M | $2.4M | $2.4M | $2.6M | $2.9M | $3.2M | $3.2M | $6.80B |
| Gastos Operativos | $1.2M | $16.6M | $3.4M | $4.3M | $6.5M | $9.1M | $10.5M | $8.8M | $16.2M | $16.7M |
| Beneficio Operativo | -$1.2M | -$16.6M | -$3.4M | -$4.3M | -$6.5M | -$9.1M | -$10.5M | -$8.8M | -$16.2M | -$16.7M |
| EBITDA | $8032 | -$16.6M | 0 | -$4.2M | 0 | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| Gastos por Intereses | $7232 | $48255 | $103215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.2M | -$16.6M | -$3.3M | -$4.2M | -$6.3M | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| Impuestos | $800 | 0 | -$71615 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$1.2M | -$16.6M | -$3.2M | -$4.2M | -$6.3M | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| BPA | $-0.12 | $-1.59 | $-0.31 | $-0.40 | $-0.58 | $-0.73 | $-0.83 | $-0.58 | $-1.36 | $-1.85 |
| BPA Diluido | $-0.12 | $-1.59 | $-0.31 | $-0.40 | $-0.58 | $-0.73 | $-0.83 | $-0.58 | $-1.36 | $-1.85 |
| Acciones en Circulación (Diluidas) | $9.9M | $10.4M | $10.4M | $10.6M | $11.0M | $12.5M | $12.7M | $14.5M | $11.5M | $7.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$4.1M | -$6.2M | -$5.2M | -$6.6M |
| EBITDA | -$4.1M | -$5.2M | -$3.9M | -$5.3M |
| Beneficio Neto | -$3.4M | -$5.2M | -$3.9M | -$5.3M |
| BPA | $-0.48 | $-0.78 | $-0.46 | $-0.62 |
| BPA Diluido | $-0.48 | $-0.78 | $-0.46 | $-0.62 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $2.1M | $9.0M | $6.9M | $13.2M | $16.7M | $20.3M | $8.2M | $7.3M | $45.8M | $61.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $4.9M | 0 | $14.4M | $78.6M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.1M | $9.1M | $7.3M | $13.2M | $16.8M | $20.5M | $13.2M | $7.3M | $60.3M | $140.5M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | $61228 | $12646 | 0 | $254921 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $730.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $2.9M | $9.9M | $7.3M | $13.4M | $16.9M | $20.5M | $13.2M | $7.3M | $60.3M | $140.7M |
| Cuentas por Pagar | $64510 | $311867 | $399551 | $724165 | $1.2M | $1.6M | $3.1M | $1.8M | $2.3M | $2.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $64510 | $311867 | $399551 | $724165 | $1.2M | $1.6M | $3.1M | $1.8M | $5.3M | $2.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $64510 | $311867 | $399551 | $724165 | $1.2M | $1.6M | $3.1M | $1.8M | $5.3M | $2.9M |
| Reservas | -$1.9M | -$18.4M | -$21.7M | -$25.9M | -$32.2M | -$41.3M | -$51.8M | -$60.2M | -$75.8M | -$89.5M |
| Patrimonio Neto | $2.8M | $9.6M | $6.9M | $12.6M | $15.7M | $18.9M | $10.1M | $5.6M | $55.0M | $137.8M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | 0 | $8408 | 0 | 0 | $154920 |
| Deuda Neta | -$2.1M | -$9.0M | -$6.9M | -$13.2M | -$16.7M | -$20.3M | -$13.1M | -$7.3M | -$60.2M | -$140.2M |
| Capital Circulante | $2.0M | $8.8M | $6.9M | $12.5M | $15.6M | $18.9M | $10.0M | $5.6M | $55.0M | $137.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $127.7M | $61.8M | $52.5M | $52.8M |
| Activos Totales | $144.2M | $140.7M | $138.0M | $135.0M |
| Pasivos Totales | $2.6M | $2.9M | $2.6M | $4.1M |
| Patrimonio Neto | $141.6M | $137.8M | $135.4M | $130.9M |
| Deuda Total | $102236 | $154920 | $131565 | $107829 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.2M | -$16.6M | -$3.2M | -$4.2M | -$6.3M | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| Amortizaciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $305205 | $529332 | $1.0M | $1.3M | $1.5M | $1.6M | $1.9M | $1.1M | $4.8M |
| Cambio en Capital Circulante | -$9035 | $120577 | -$188157 | $196024 | $443809 | $317769 | $1.6M | -$1.4M | $3.5M | -$2.6M |
| Flujo de Caja Operativo | -$1.2M | -$2.6M | -$2.9M | -$3.0M | -$4.7M | -$7.3M | -$7.2M | -$7.9M | -$6.4M | -$12.2M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | $1 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$35.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.2M | -$2.6M | -$2.9M | -$3.0M | -$4.7M | -$7.3M | -$7.2M | -$7.9M | -$6.4M | -$12.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.1M | -$3.4M | -$3.5M | -$3.25B |
| Inversiones (CapEx) | 0 | 0 | -$4 | 0 |
| Flujo de Caja Libre | -$2.1M | -$3.4M | -$3.5M | -$3.25B |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.1M | $1.1M | $1.7M | $1.43B |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -1296.3% | +80.5% | -30.9% | -49.2% | -44.4% | -15.5% | +20.1% | -85.5% | +12.0% |
| Crecimiento BPA (anual) | | -1225.0% | +80.5% | -29.0% | -45.0% | -25.9% | -13.7% | +30.1% | -134.5% | -36.0% |
| Cambio en Acciones (anual) | | +5.7% | +0.0% | +1.6% | +3.5% | +13.8% | +2.0% | +14.1% | -20.9% | -35.5% |
| Crecimiento FCF (anual) | | -119.9% | -9.9% | -4.5% | -54.5% | -56.9% | +1.2% | -8.7% | +18.5% | -90.5% |
| Tasa Impositiva Efectiva | -0.1% | -0.0% | 2.2% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.12 | $-0.25 | $-0.28 | $-0.29 | $-0.43 | $-0.59 | $-0.57 | $-0.54 | $-0.56 | $-1.65 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $9.9M | $10.4M | $10.4M | $10.6M | $11.0M | $12.5M | $12.7M | $14.5M | $11.4M | $7.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -13.08% |
| Rentabilidad sobre capital invertido | -16.89% |
| Rentabilidad sobre activos | -13.22% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 33.56 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1104.17 | -83.33 | -427.42 | -207.50 | -52.76 | -21.99 | -14.28 | -2.93 | -16.18 | -35.30 |
| P/VC | 461.24 | 143.54 | 199.58 | 69.59 | 21.37 | 10.57 | 14.94 | 4.41 | 4.57 | 3.51 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |